Market Overview:
The global 3D bioprinting market reached a value of US$ XX Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
3D bioprinting refers to an additive manufacturing technique used for the development of precise anatomical tissues through the decomposition of cell-based bio-inks. 3D bioprinting involves various deposition and assembling processes, such as direct and laser writing, microstamping, photolithography, stereolithography, electro-printing and inkjet deposition. The bio-inks are manufactured using living cells, biomaterials and active biomolecules to create 3D structures of tissues and organs. The printer deposits multiple layers of biomaterials to build complex bodily structures, such as bones, skin, vascular grafts, tracheal splints, heart tissues and cartilages. These printed structures are assembled and bonded using dissolvable gel or collagen scaffolds to support and mold the cells in the desired shape.
3D Bioprinting Market Trends:
The increasing prevalence of chronic respiratory and cardiovascular disorders (CVDs) across the globe is one of the key factors driving the growth of the market. Moreover, the rising requirement for regenerative medicines, cancer therapeutics and stem cell solutions is providing a thrust to the market growth. 3D bioprinting is widely used for liver modeling and development of various bone, tissue and medical implants. In line with this, the increasing consciousness among the masses to minimize animal testing is also contributing to the market growth. Cosmetic manufacturers use bio-printed hair follicles and skin grafts to clinically test the products on human-like tissues. Additionally, various technological advancements, such as the development of organ-on-a-chip, are acting as other growth-inducing factors. These innovative bio-printed structures enable 3D in-vitro analysis of the bodily functions and fabrication of artificial organs and tissues for regenerative medicine and tissue engineering. Other factors, including extensive research and development (R&D) activities in the field of biotechnology, along with the increasing adoption of magnetic levitation technology for toxicity screening and vascular muscle printing, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global 3D bioprinting market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on component, application and end user.
Breakup by Component:
- 3D Bioprinters
- Syringe/Extrusion Bioprinting
- Inkjet Bioprinting
- Magnetic Levitation Bioprinting
- Laser-assisted Bioprinting
- Others
- Scaffolds
- Biomaterials
- Living Cells
- Hydrogels
- Extracellular Matrices
- Others
Breakup by Application:
- Research
- Drug Research
- Regenerative Medicine
- 3D Cell Culture
- Clinical
- Skin
- Bone and Cartilage
- Blood Vessels
- Others
Breakup by End User:
- Hospitals
- Research Organization and Academic Institutes
- Biopharmaceuticals Companies
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3D Systems Inc., Aspect Biosystems Ltd., Cellink, Cyfuse Biomedical K.K., EnvisionTEC GmbH (Desktop Metal Inc.), GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH, Materialise, Organovo Holdings Inc., Poietis, RegenHU and Stratasys Ltd.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2020 |
| Historical Period |
2015-2020 |
| Forecast Period |
2021-2026 |
| Units |
US$ Billion |
| Segment Coverage |
Component, Application, End User, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
3D Systems Inc., Aspect Biosystems Ltd., Cellink, Cyfuse Biomedical K.K., EnvisionTEC GmbH (Desktop Metal Inc.), GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH, Materialise, Organovo Holdings Inc., Poietis, RegenHU and Stratasys Ltd. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global 3D bioprinting market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global 3D bioprinting market?
- What are the key regional markets?
- What is the breakup of the market based on the component?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global 3D bioprinting market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global 3D Bioprinting Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Component
6.1 3D Bioprinters
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Syringe/Extrusion Bioprinting
6.1.2.2 Inkjet Bioprinting
6.1.2.3 Magnetic Levitation Bioprinting
6.1.2.4 Laser-assisted Bioprinting
6.1.2.5 Others
6.1.3 Market Forecast
6.2 Scaffolds
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Biomaterials
6.3.1 Market Trends
6.3.2 Key Segments
6.3.2.1 Living Cells
6.3.2.2 Hydrogels
6.3.2.3 Extracellular Matrices
6.3.2.4 Others
6.3.3 Market Forecast
7 Market Breakup by Application
7.1 Research
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 Drug Research
7.1.2.2 Regenerative Medicine
7.1.2.3 3D Cell Culture
7.1.3 Market Forecast
7.2 Clinical
7.2.1 Market Trends
7.2.2 Key Segments
7.2.2.1 Skin
7.2.2.2 Bone and Cartilage
7.2.2.3 Blood Vessels
7.2.2.4 Others
7.2.3 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Research Organization and Academic Institutes
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Biopharmaceuticals Companies
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 3D Systems Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Aspect Biosystems Ltd.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Cellink
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.4 Cyfuse Biomedical K.K.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 EnvisionTEC GmbH (Desktop Metal Inc.)
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Materialise
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Organovo Holdings Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.9 Poietis
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 RegenHU
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Stratasys Ltd.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
List of Figures
Figure 1: Global: 3D Bioprinting Market: Major Drivers and Challenges
Figure 2: Global: 3D Bioprinting Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: 3D Bioprinting Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: 3D Bioprinting Market: Breakup by Component (in %), 2020
Figure 5: Global: 3D Bioprinting Market: Breakup by Application (in %), 2020
Figure 6: Global: 3D Bioprinting Market: Breakup by End User (in %), 2020
Figure 7: Global: 3D Bioprinting Market: Breakup by Region (in %), 2020
Figure 8: Global: 3D Bioprinting (3D Bioprinters) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: 3D Bioprinting (3D Bioprinters) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: 3D Bioprinting (Scaffolds) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: 3D Bioprinting (Scaffolds) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: 3D Bioprinting (Biomaterials) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: 3D Bioprinting (Biomaterials) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: 3D Bioprinting (Research) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: 3D Bioprinting (Research) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: 3D Bioprinting (Clinical) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: 3D Bioprinting (Clinical) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: 3D Bioprinting (Hospitals) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: 3D Bioprinting (Hospitals) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: 3D Bioprinting (Research Organization and Academic Institutes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: 3D Bioprinting (Research Organization and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: 3D Bioprinting (Biopharmaceuticals Companies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: 3D Bioprinting (Biopharmaceuticals Companies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: North America: 3D Bioprinting Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: North America: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: United States: 3D Bioprinting Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: United States: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Canada: 3D Bioprinting Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Canada: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Asia-Pacific: 3D Bioprinting Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Asia-Pacific: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: China: 3D Bioprinting Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: China: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Japan: 3D Bioprinting Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Japan: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: India: 3D Bioprinting Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: India: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: South Korea: 3D Bioprinting Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: South Korea: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: Australia: 3D Bioprinting Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: Australia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Indonesia: 3D Bioprinting Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Indonesia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Europe: 3D Bioprinting Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: Europe: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Germany: 3D Bioprinting Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Germany: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: France: 3D Bioprinting Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: France: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: United Kingdom: 3D Bioprinting Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: United Kingdom: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Italy: 3D Bioprinting Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: Italy: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Spain: 3D Bioprinting Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Spain: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Russia: 3D Bioprinting Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Russia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Latin America: 3D Bioprinting Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Latin America: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Brazil: 3D Bioprinting Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Brazil: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Mexico: 3D Bioprinting Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Mexico: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Middle East and Africa: 3D Bioprinting Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Middle East and Africa: 3D Bioprinting Market: Breakup by Country (in %), 2020
Figure 72: Middle East and Africa: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Global: 3D Bioprinting Industry: SWOT Analysis
Figure 74: Global: 3D Bioprinting Industry: Value Chain Analysis
Figure 75: Global: 3D Bioprinting Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: 3D Bioprinting Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: 3D Bioprinting Market Forecast: Breakup by Component (in Million US$), 2021-2026
Table 3: Global: 3D Bioprinting Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 4: Global: 3D Bioprinting Market Forecast: Breakup by End User (in Million US$), 2021-2026
Table 5: Global: 3D Bioprinting Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: 3D Bioprinting Market: Competitive Structure
Table 7: Global: 3D Bioprinting Market: Key Players